Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel activation-condensation route for Sitagliptin intermediates. High yield, industrial scalability, cost-effective alternative to HOBt/EDC methods.
Patent CN101817783B details a high-yield synthesis of Tolvaptan intermediates via optimized acid chloride activation, offering significant cost reduction in API manufacturing.
Patent CN108976186B details a copper-catalyzed C-H activation route for tetra-substituted furans, offering significant cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN116903534A reveals a novel one-pot synthesis for phthalimide spironaphthalenone. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN111533684B reveals a novel quaternary ammonium activation strategy for pyridine alkenylation, offering high yields and simplified synthesis for reliable API intermediate manufacturing.
Patent CN109516946B reveals a novel one-step carbazole synthesis using anthranilic acids, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN110862396A details a novel Pd-catalyzed synthesis for pyrrolo[3,4-c]carbazole-1,3-diones. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with scalable routes.
Patent CN111808023B reveals a novel C-H activation method for 3-aryl isoquinoline derivatives using alkynyl carboxylic acids, offering significant cost reduction and supply chain stability.
Patent CN111808023B reveals a green Co-catalyzed route to 3-arylisoquinolines using alkynyl carboxylic acids, offering cost-effective pharma intermediate manufacturing.
Patent CN117586310A reveals a novel Ni-Al bimetallic catalyst for enantioselective C(sp3)-H activation, offering cost reduction in pharmaceutical intermediates manufacturing and high-purity chiral nitrogen-containing heterocycles.
Efficient rhodium-catalyzed cyclization of pyridine and alkynes for high-purity pharmaceutical intermediates with simplified purification and mild reaction conditions.
Patent CN105218426A details oxygen-driven rhodium catalysis for indole and isoquinoline derivatives, offering cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN104254538A reveals stable boronated derivatives enabling scalable Suzuki coupling for high-performance organic semiconductor materials and display applications.
Novel C-H activation patent CN113861228B enables efficient alkyl borane synthesis. Delivers supply chain reliability and cost reduction for pharmaceutical intermediate manufacturing.
Patent CN111484528A reveals a novel halogenation route for TAF intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Advanced synthesis of 2-chloronicotinic acid via solid phosgene. Reduces phosphorus waste and enhances safety for reliable agrochemical intermediate supply chains.
Patent CN114716454A details a novel Rh(III) synthesis for nitrogen-oxygen fused rings, offering cost-effective routes for organic semiconductor intermediates and display materials.
Discover a novel synthesis method for Panipenem intermediates avoiding hazardous azides. Offers significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN104370930B reveals rhodium-catalyzed synthesis for electronic chemicals. Achieve higher yields and simplified supply chains for optoelectronic materials manufacturing.
Patent CN101415719A details efficient L-deoxycytidine production. Offers cost reduction in antiviral manufacturing and reliable supply chain solutions.